000			01333 a2200397 4500
005			20250513223309.0
264		0	_c20010109
008			200101s 0 0 fre d
022			_a0398-0499
040			_aNLM _beng _cNLM
100	1		_aPottier, P
245	0	0	_a[Rationalization of risk factors for venous thromboembolism in medical inpatients. A prospective study]. _h[electronic resource]
260			_bJournal des maladies vasculaires _cOct 2000
300			_a241-9 p. _bdigital
500			_aPublication Type: Clinical Trial; Controlled Clinical Trial; English Abstract; Journal Article; Multicenter Study
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnticoagulants _xtherapeutic use
650	0	4	_aFrance _xepidemiology
650	0	4	_aHeparin, Low-Molecular-Weight _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aInpatients
650	0	4	_aMiddle Aged
650	0	4	_aNadroparin _xtherapeutic use
650	0	4	_aProspective Studies
650	0	4	_aRisk Factors
650	0	4	_aThromboembolism _xepidemiology
650	0	4	_aVenous Thrombosis _xepidemiology
700	1		_aPlanchon, B
700	1		_aTruchaud, F
700	1		_aPistorius, M A
700	1		_aFuric, I
700	1		_aGrolleau, J Y
773	0		_tJournal des maladies vasculaires _gvol. 25 _gno. 4 _gp. 241-9
999			_c11002951 _d11002951